MedPath

Samik Pharmaceutical Co. Ltd.

🇰🇷South Korea
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.samik.co.kr

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of SIPS-2209-1 in Healthy Korean Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: SIPS-2209-2, SIPS-2209-3
First Posted Date
2023-03-28
Last Posted Date
2023-04-18
Lead Sponsor
Samik Pharmaceutical Co. Ltd.
Target Recruit Count
40
Registration Number
NCT05787873
Locations
🇰🇷

Samik Pharmaceutical Co. Ltd., Incheon, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.